All News

2017

February

Media Release / Feb 08, 2017

Sandoz certified as Top Employer Europe 2017

Read More
Media Release / Feb 07, 2017

Sandoz confirms strategic commitment to drive access to medicines in Japan, with plan to double business by 2022

Read More

January

Media Release / Jan 25, 2017

Novartis delivered solid 2016 performance, with Growth Products[1] absorbing Gleevec US LOE; innovation momentum continued; announces share buyback

Read More
2016

December

Media Release / Dec 05, 2016

New interim data demonstrate Sandoz proposed biosimilar rituximab has equivalent efficacy to reference product

Read More

November

Media Release / Nov 22, 2016

Sandoz to donate up to USD 10 million of high-quality generic medicines annually to Americares to increase access to medicines

Read More
Media Release / Nov 18, 2016

Innovative study with three treatment switches confirms Sandoz biosimilar etanercept has equivalent efficacy to originator

Read More

October

Media Release / Oct 25, 2016

Novartis delivered solid third quarter with Growth Products[1] offsetting Gleevec patent expiration; several positive readouts for potential blockbusters

Read More

September

Media Release / Sep 28, 2016

Sandoz invites young entrepreneurs to enter Sandoz HACk, a global competition to help solve healthcare access challenges

Read More
Media Release / Sep 16, 2016

Top-line results for PF-06438179 (biosimilar infliximab) demonstrate equivalent efficacy to reference product

Read More

August

Media Release / Aug 31, 2016

AirFluSal® Forspiro® showed superiority at 12 months over Seretide® Diskus®[1] in persistence to treatment

Read More